Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Actemra Tocilizumab 162mg Solution for injection Roche Products (NZ) Limited Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Sumatriptan (Prescription) Sumatriptan succinate 70.08mg equivalent to Sumatriptan 50mg Film coated tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Dadra and Nagar Haveli, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Sumatriptan (Restricted) Sumatriptan succinate 70.08mg equivalent to Sumatriptan 50mg Film coated tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Dadra and Nagar Haveli, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Sumatriptan Sumatriptan succinate 140.15mg equivalent to Sumatriptan 100mg Film coated tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Dadra and Nagar Haveli, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Ipca-Sumatriptan Sumatriptan succinate 70.08mg equivalent to Sumatriptan 50mg Film coated tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Dadra and Nagar Haveli, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Ipca-Sumatriptan Sumatriptan succinate 140.15mg equivalent to Sumatriptan 100mg Film coated tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Dadra and Nagar Haveli, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Valganciclovir Mylan Valganciclovir hydrochloride 496.3mg equivalent to Valganciclovir 450mg Film coated tablet Mylan New Zealand Limited Mylan Laboratories Limited, Maharashtra State India
|
Dated this 27th day of March 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).